Explore how machine learning meets human style in caps designed for the AI age, blending smart design, personalization, and ...
Company announcement - No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results